Biomedical Co. Clearside Gets OK For $4M Ch. 11 Sale
By Clara Geoghegan · June 9, 2026, 2:03 PM EDT
Eye disease treatment developer Clearside Biomedical received a Delaware bankruptcy judge's approval on Tuesday to sell certain assets for $4 million to its stalking horse....
To view the full article, register now.